Target intelligence / Profile preview

MHC class I chain-related protein A/B (MICA/B)

Target
MICA/B
Molecular classification
Other (MHC class I-like molecule, not a classical antigen-presenting molecule), Ligand for activating immunoreceptor (NKG2D), Cell surface glycoprotein
01

Overview

MHC class I chain-related proteins A and B (MICA and MICB) are highly polymorphic cell surface glycoproteins encoded within the major histocompatibility complex locus. Unlike classical MHC class I molecules, they do not associate with β2-microglobulin nor present peptides. Instead, they function primarily as stress-induced ligands that activate immune responses by binding to the NKG2D receptor on natural killer cells, γδ T cells, and CD8+ αβ T cells. This interaction serves as a "kill me" signal to cytotoxic lymphocytes when a cell is under stress due to infection or transformation. While their expression is upregulated in many tumor types—making them potential targets for cancer immunotherapy—they are also expressed intracellularly in most normal epithelial tissues with only occasional cell surface localization. This broad tissue distribution presents challenges for selective therapeutic targeting[3][5][6].

Other names
MICAMICBMHC class I polypeptide–related sequence A (for MICA)Major histocompatibility complex class I chain-related protein A and BStress-induced ligand for NKG2D receptor
02

Biological functions

Immune response modulationStress-induced signaling ("danger signal")Activation of natural killer (NK) cells, γδ T cells, and CD8+ αβ T cells via NKG2D receptor
03

Disease associations

Cancer (high expression in many tumor types)Infection (induced by cellular stress or transformation)
04

Safety considerations

Broad expression in normal epithelial tissues as well as tumors may limit therapeutic window or specificity for cancer targeting

Beyond the preview

Go deeper on MHC class I chain-related protein A/B (MICA/B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MHC class I chain-related protein A/B (MICA/B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call